Literature DB >> 10347295

A prospective randomized controlled trial of sclerotherapy vs ligation in the prophylactic treatment of high-risk esophageal varices.

P Svoboda1, I Kantorová, J Ochmann, L Kozumplík, J Marsová.   

Abstract

BACKGROUND: Endoscopic ligation (EVL) and endoscopic sclerotherapy (EIS) are both effective in the treatment of bleeding esophageal varices, but the efficacy of the two techniques in the prophylaxis of first variceal bleeding has not been investigated. The aim of this study was to investigate the frequency of first variceal bleeding, the recurrence of varices, and survival after treatment with the two techniques, as compared to a nontreated control group.
METHODS: A total of 157 patients with liver cirrhosis and advanced esophageal varices with no previous history of upper gastrointestinal bleeding were randomly assigned to either an EIS group (n = 55), an EVL group (n = 52), or a nontreated control group (n = 50). After the eradication of esophageal varices in the EIS and in EVL groups and in all control patients, the endoscopic examination was performed at 3-month intervals.
RESULTS: There were no significant differences between EIS and EVL in the eradication rate of esophageal varices (85% in the EIS group versus 81% in the EVL group). The mean number of sessions required to obtain eradication was lower in the EVL group than in the EIS group (4.8 +/- 1.8 versus 6.2 +/- 2.0; p = 0.0003), but the recurrence of esophageal varices was higher in the EVL group (31% versus 11%; p = 0.01). Total mortality was significantly lower in the EIS patients than in the controls (20% versus 38%; p = 0.04). It was also lower, but not significantly, in the EVL patients than in the controls (23% versus 38%; p = 0.10). A significant decrease in variceal bleeding was observed both in sclerotherapy cases (20%) and controls (54%; p = 0.0005) and in ligation cases and controls (29%; p = 0.01). No significant difference in bleeding episodes was observed between the sclerotherapy and ligation cases (p = 0.29). No serious complications were observed either in the EIS or EVL groups.
CONCLUSIONS: EIS and EVL are similarly effective in the prevention of first variceal bleeding. The choice between EIS and EVL depends on the skill of the endoscopic unit. For highly experienced surgeons facing no complications, sclerotherapy seems to be preferable; for all others, it is technically easier to perform ligation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10347295     DOI: 10.1007/s004649901045

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  20 in total

1.  Complete esophageal obstruction following endoscopic variceal ligation.

Authors:  Matthew A Nikoloff; Thomas R Riley; Ian R Schreibman
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-08

2.  Study of hemodynamic changes in portal systemic shunts and their relation to variceal relapse after endoscopic variceal ligation combined with ethanol sclerotherapy.

Authors:  Kenji Ito; Shoichi Matsutani; Hitoshi Maruyama; Taro Akiike; Hiromasa Nomoto; Toshiya Suzuki; Takeshi Fukuzawa; Hideaki Mizumoto; Hiromitsu Saisho
Journal:  J Gastroenterol       Date:  2006-02       Impact factor: 7.527

3.  Band ligation versus no intervention for primary prevention of upper gastrointestinal bleeding in adults with cirrhosis and oesophageal varices.

Authors:  Sonam Vadera; Charles Wei Kit Yong; Lise Lotte Gluud; Marsha Y Morgan
Journal:  Cochrane Database Syst Rev       Date:  2019-06-20

4.  Endoscopic injection sclerotherapy with ethanolamine oleate with iopamidol for esophagojejunal varices in idiopathic portal hypertension.

Authors:  Koichi Soga; Koichi Tomikashi; Ki-ichiro Miyawaki; Kotaro Okuda; Yusuke Sugiyama; Shuji Sekikawa; Naoki Wakabayashi; Hideyuki Konishi; Shoji Mitsufuji; Keisho Kataoka; Toshikazu Yoshikawa
Journal:  Dig Dis Sci       Date:  2008-09-20       Impact factor: 3.199

5.  Dual red imaging (novel advanced endoscopy) can increase visibility and can predict the depth in diagnosing esophageal varices.

Authors:  Yoshihiro Furuichi; Takuji Gotoda; Fuminori Moriyasu; Saori Ogawa; Yoshitaka Kasai; Hirohito Takeuchi; Yuu Yoshimasu; Takatomo Sano; Katsutoshi Sugimoto; Takashi Kawai; Yoshiyuki Kobayashi; Ikuo Nakamura; Takao Itoi
Journal:  J Gastroenterol       Date:  2016-08-08       Impact factor: 7.527

Review 6.  Evidence-based clinical practice guidelines for liver cirrhosis 2015.

Authors:  Hiroshi Fukui; Hidetsugu Saito; Yoshiyuki Ueno; Hirofumi Uto; Katsutoshi Obara; Isao Sakaida; Akitaka Shibuya; Masataka Seike; Sumiko Nagoshi; Makoto Segawa; Hirohito Tsubouchi; Hisataka Moriwaki; Akinobu Kato; Etsuko Hashimoto; Kojiro Michitaka; Toshikazu Murawaki; Kentaro Sugano; Mamoru Watanabe; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2016-05-31       Impact factor: 7.527

7.  Foam sclerotherapy using polidocanol for balloon-occluded retrograde transvenous obliteration (BRTO).

Authors:  Sun Young Choi; Jong Yun Won; Kyung Ah Kim; Do Yun Lee; Kwang-Hun Lee
Journal:  Eur Radiol       Date:  2010-08-26       Impact factor: 5.315

Review 8.  Endoscopic treatments for portal hypertension.

Authors:  Gin-Ho Lo
Journal:  Hepatol Int       Date:  2017-11-07       Impact factor: 6.047

9.  Results of a new method to stop acute bleeding from esophageal varices: implantation of a self-expanding stent.

Authors:  J Zehetner; A Shamiyeh; W Wayand; R Hubmann
Journal:  Surg Endosc       Date:  2008-07-12       Impact factor: 4.584

10.  Primary prevention of variceal bleeding in people with oesophageal varices due to liver cirrhosis: a network meta-analysis.

Authors:  Davide Roccarina; Lawrence Mj Best; Suzanne C Freeman; Danielle Roberts; Nicola J Cooper; Alex J Sutton; Amine Benmassaoud; Maria Corina Plaz Torres; Laura Iogna Prat; Mario Csenar; Sivapatham Arunan; Tanjia Begum; Elisabeth Jane Milne; Maxine Tapp; Chavdar S Pavlov; Brian R Davidson; Emmanuel Tsochatzis; Norman R Williams; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2021-04-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.